Barrington Research Maintains Outperform on Orthofix Medical, Maintains $18 Price Target
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and maintains $18 price target.
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and maintains $18 price target.